Cracking US Reimbursement: A Guide for UK Founders and Angel Investors
🇺🇸 The US is the largest healthcare market in the world and one of the hardest to navigate⚕️
🇬🇧 For UK founders and angel investors, understanding how reimbursement actually works is often the difference between a business plan that scales and one that stalls.
Join HSBC Innovation Banking and Sie Ventures for a practical session built specifically for a UK audience, led by Dave Nelson and his team at HealthScape Advisors, a Chartis company, and Ty Kayam of Wilson Sonsini. Together they advise payers, providers and health-tech companies on navigating the US regulatory and reimbursement landscape.
The session is designed to give a clear foundation, assuming limited prior exposure to the US system, and to leave you with a sharper way to scope milestones and de-risk investments. We will cover:
How US reimbursement works, including the key players and decision points across Medicare and CMS, Medicaid and commercial payers, and how coverage, coding and payment fit together.
How to build a reimbursement plan and a realistic timeline to revenue, including the major milestones, evidence requirements and common pitfalls that affect speed to payment.
How this differs across medical devices, diagnostics, and digital health and services, since each follows a distinct path to coverage and cash flow.
The current policy dynamics that carry investment risk, including Medicaid funding uncertainty, prior authorisation reform, and the wider federal and state regulatory picture, with a look at notable regional and rural initiatives such as the CMS Rural Health Transformation Program.
Sapna Shah of Sie Ventures will then give a short overview of the early-stage investment landscape and how reimbursement realities shape margin profiles, milestones and valuations.
You will leave with a shared understanding of the reimbursement landscape and a more concrete way to evaluate, or build, business plans that can scale and generate revenue.
To help us understand who is in the room and how to cater the webinar please fill the survey out if you are asking to join. https://www.surveymonkey.com/r/KJRFBCS.
📋 Agenda
4:30pm Arrival and welcome
4:45pm Panel: the US reimbursement landscape, with HealthScape Advisors
5:30pm The early-stage investment view, with Sapna Shah (Sie Ventures)
5:45pm Audience Q&A
6:00pm 🍸 Drinks and networking on the deck
🎤 Speakers
Dave Nelson (Partner), HealthScape Advisors. Dave advises health service and technology-enabled companies on US market trends, delivery models and emerging alternative payment models, and works with payer and provider start-ups on operating models, capital raises and product design. His earlier career spans senior federal-markets and health-plan leadership, including VP of Federal Markets at OptumHealth and President and COO of a multi-state TRICARE start-up health plan covering 1.2 million lives. He began his career in the US Navy, Medical Service Corps, and holds a Master's in Hospital and Health Administration from the University of Iowa.
David Sann (Partner), HealthScape Advisors. David brings over 25 years of experience as both a health-plan executive and strategic advisor. He specialises in transforming and optimising health-plan operations, launching new delivery models, and advising on US government compliance and acquisition. He spent more than 15 years at Optum leading payer businesses across care and utilisation management, and has implemented large-scale government programmes including the TRICARE for Life Medicare supplemental scheme. He holds graduate and undergraduate degrees in Government and Politics from the University of Maryland.
Mike Ferson (Senior Partner), HealthScape Advisors. Mike has spent the last 15 years advising healthcare payers and providers on growth and financial optimisation. He specialises in value-based payment policy, programme design, and the contracting and organisational structures that let payers, providers and partners deliver value across both commercial and government markets. He earned his MBA from the University of Chicago Booth School of Business and his economics degree from Kenyon College.
Ty Kayam (Of Counsel), Wilson Sonsini. Ty advises companies and investors on regulatory strategy for health technology, with a focus on health AI, digital health and medical devices. She was previously the first attorney in the FDA's Digital Health Center of Excellence, where she worked on the agency's approach to AI-enabled medical devices, and before that was senior corporate counsel for Microsoft's health AI portfolio. She received the 2025 FDA Digital Health Above and Beyond Award.
Sapna Shah (Syndicate Lead and Venture Partner), Sie Ventures. Sapna brings two decades of finance leadership to early-stage investing, with an angel focus on women's health and healthcare. She leads the Sie syndicate backing female founders across all sectors and supports the Arāya Sie Fund, which backs female founders building companies focused on how we manage our health, grow our wealth, live sustainably and harness intelligence.
🙌 Hosted by
Sapna Shah, Syndicate Lead and Venture Partner at Sie Ventures, brings two decades of finance leadership to early-stage investing, with an angel focus on women's health and healthcare. She leads the Sie syndicate backing female founders across all sectors and supports the Arāya Sie Fund. Sapna will also give a short overview of the early-stage investment landscape during the session.
Nicole Scola leads the early-stage Consumer and HealthTech portfolio at HSBC Innovation Banking, partnering with founders from Seed to Series A. She began her career at SVB in Boston, became a founding member of Northwell Holdings, the corporate venture arm of New York State's largest healthcare system, where she led joint ventures and commercialisation strategy across consumer health and medical device products, and later served as Director of Strategy at Shields Health Solutions, supporting partnerships with more than 80 US health systems.
🏦 About HSBC Innovation Banking
HSBC Innovation Banking provides commercial banking services, expertise and insights to the technology, life science and healthcare, private equity and venture capital industries. HSBC Innovation Banking is a subsidiary of HSBC Group, benefiting from its stability, strong credit rating and international reach to help fuel its growth.
🌱 About Sie Ventures
Sie Ventures is a capital platform backing female founders, running an active syndicate alongside the Arāya Sie Fund, which invests in female founders building companies focused on how we manage our health, grow our wealth, live sustainably and harness intelligence.
🩺 About HealthScape Advisors
HealthScape Advisors, a Chartis company, advises healthcare payers, providers and technology-enabled companies across the US commercial and government markets, with deep experience in value-based care, market strategy and federal and state programmes.
⚖️ About Wilson Sonsini
Wilson Sonsini Goodrich & Rosati is a leading global law firm advising technology, life sciences and healthcare companies, and the investors who back them, at every stage from formation to exit. Its healthcare and FDA regulatory team helps founders navigate the US regulatory landscape, from offices across the US, Europe and Asia, including London.
By registering for this event, you agree that the details you provide may be shared with the event hosts and partners, HSBC Innovation Banking and Sie Ventures, who may contact you about this event and related updates. You can opt out at any time.
© 2026 HSBC Innovation Bank Limited. All rights reserved. HSBC Innovation Bank Limited (trading as HSBC Innovation Banking) is registered in England and Wales at Alphabeta, 14-18 Finsbury Square, London EC2A 1BR, UK (Company Number 12546585). HSBC Innovation Bank Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority (Firm Reference Number 543146). HSBC Innovation Bank Limited is part of the HSBC Group. HSBC Innovation Bank Limited is not licenced to undertake banking business or any other regulated activity in Sweden and Denmark. HSBC Innovation Bank Limited is committed to making its website and related documents accessible to everyone. Learn more on www.hsbcinnovationbanking.com/accessibility
If you no longer wish to receive marketing communications from HSBC Innovation Banking you may unsubscribe.
© 2026 Sie Ventures Ltd. All rights reserved. Sie Ventures Ltd is registered in England and Wales at 20-22 Wenlock Road, London, N1 7GU (Company Number 13472977). Your personal data will be handled in line with the Sie Ventures privacy policy at www.sie.ventures.
If you no longer wish to receive communications from Sie Ventures you may unsubscribe.